[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601950":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":33,"responsibleParty":53,"collaborators":18,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":18,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":18,"enrollmentInfo":64,"targetDuration":18,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":18,"overallStatus":35,"whyStopped":18,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"VA Pittsburgh Healthcare System","FED",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ADRD Care Delivery Protocol","EXPERIMENTAL","Patients will undergo telehealth preparedness assessment, cognitive screening, and blood biomarker testing prior to the initial consultation with the specialist.",[13],"Other: ADRD Care Delivery Protocol",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","NO_INTERVENTION","Patients will undergo usual care with all evaluation and testing at the discretion of the specialist.",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"OTHER","1\\. Included in arm\u002Fgroup descriptions",[9],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Alison O'Donnell, DO, MPH","CONTACT","412-522-3123","alison.odonnell2@va.gov",{"name":31,"role":27,"phone":18,"phoneExt":18,"email":32},"Julie Faieta, PhD","juf52@pitt.edu",[34],{"facility":5,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Pittsburgh","Pennsylvania","15240","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-79.99589,40.44062,{"lat":45,"lon":44},[48,49,50,52],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},{"name":31,"role":27,"phone":18,"phoneExt":18,"email":32},{"name":26,"role":51,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"name":31,"role":51,"phone":18,"phoneExt":18,"email":18},{"type":54,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100601950","improving-access-to-care-for-veterans-with-memory-loss-100601950",false,"NCT07117162","Improving Access to Care for Veterans With Memory Loss","Increasing Access to Care: An Advanced Virtual Care Delivery Protocol to Deliver Diagnostic and Therapeutic Services to Underserved Veterans With ADRD","Inclusion Criteria:\n\n* Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score \\>7\n* Meets VA MUE inclusion\u002Fexclusion criteria for mAb therapy for AD\n* Enrolled in VA care\n* Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital)\n* Has a working telephone\n* 18 years and older\n* Able to communicate in English\n* Willing to give informed consent.\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":65,"type":66},30,"ESTIMATED","INTERVENTIONAL",[69],"NA","This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.",[72],"Alzheimer Disease","2025-10-30",{"date":75,"type":76},"2025-11-03","ACTUAL",{"date":78,"type":76},"2025-10-29",{"date":80,"type":66},"2027-06",{"name":5,"class":6},1]